According to SPER Market Research, the Proteomics Market is anticipated to grow at a 15.2% CAGR to reach USD 92.55 billion. The need for protein research and gene sequencing has risen due to the increasing occurrence of infectious illnesses. This research can aid in the creation of cutting-edge medicines for cancer, viral illnesses, and other genetic problems.
A thorough investigation of proteins is called proteomics. An organism’s collection of proteins is known as its proteome. Identification of an organism’s composition, activity, structure, and stressors is made easier with the aid of proteome research. This research can be used to create medicines for viruses, tumours, and genetic abnormalities.
Global Proteomics Market Overview (2022-2030)
- Forecast CAGR (2022-2030): 15.2%
- Forecast Market Size (2030): 92.55 billion
According to market share, the market for reagents used in immunoassays is the largest reagent market. The substantial proportion of this market is primarily attributed to the availability of a variety of reagents, their dependability and specificity, and their speed of detection. Due to increased financing and investments, a growing emphasis on the high quality of research outputs, a rise in the demand for customised medications, and the presence of major market participants in North America, this region led the global market by geographical segmentation.
Impact of COVID-19 on the Proteomics Market
The COVID-19 pandemic has increased the focus on decoding 3d structures of SARS-CoV-2 proteins. In order to understand therapies against COVID-19, protein crystallization techniques have played a significant role to understand virus proteins and specific sites. This has impacted the proteomics market in positively and the marker has grown further.
Request For Free sample report @ https://www.sperresearch.com/report-store/Proteomics.aspx?sample=1
Global Proteomics Market Key Segments Covered
The SPER Market Research report seeks to give market dynamics, demand, and supply forecasts for the years up to 2030. This report contains statistics on product type segment growth estimates and forecasts.
By Technology:
- Spectroscopy
- Chromatography
- Electrophoresis
- Protein Microarrays
- Micrparray Instruments
- X-Ray Crystallography
- Surface Plasmon Resonance
- Protein Fractionation
By Reagents:
- Immunoassay Reagents
- Spectroscopy Reagents
- Chromatography Reagents
- Protein Microarray Reagents
- X-Ray Crystallography Reagents
- Electrophoresis Reagents
- Protein Fractionation Reagents
By Software & Services:
- Core Proteomics Services
- Bioinformatics Software and Services
By Application:
- Clinical Diagnostics
- Drug Discovery
- Other Application
By End User:
- Hospitals
- Clinical Laboratories
- Pharmaceutical Companies
- Academic Research Laboratories
- Others
By Region:
- North America
- Europe
- Asia-Pacific
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends, and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Global Proteomics Market Key Players:
The global proteomics market study provides market data by the competitive landscape, revenue analysis, segments, and detailed analysis of key market players such as Agilent Technologies, Inc., Applied Biomics, Inc., Biognosys AG, Biomax Informatics AG, Bioproximity, Bio-Rad Laboratories, Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, Eurofins Scientific, Fios Genomics Ltd., GE Healthcare, GENEWIZ, HORIBA, Ltd., Illumina, Inc., Integrated Applications, Luminex Corporation, Merck KGaA, MRM Proteomics Inc., MS Bioworks LLC, PerkinElmer Inc., Poochon Scientific, LLC, Promega Corporation, Proteome Factory AG, QIAGEN Bioinformatics.
Contact Us:
SPER Market Research
Lucioa Jones, Business Consultant – U.S.A.
+1-347-460-2899
